Dr. Husain’s research has focused on the risk factors and outcomes of infections in solid organ transplant recipients. His funded clinical research is directed towards the evaluation of diagnostic and prognostic tests for early diagnosis of invasive aspergillosis. His laboratory work focuses on finding novel biomarkers of susceptibility of invasive aspergillosis in immunocompromised hosts. He is also involved in the development of appropriate antiviral and antifungal prophylactic strategies in immunocompromised hosts. He works actively on the association of Aspergillus infection and development of chronic rejection in lung transplant recipients.